Skip to content
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Jushi Holdings Inc. JUSH

6 fiscal years on record · USD · FY2025 reported · SEC filings only
$262.9M
▲ 2.1% YoY
$-68.6M
$1.6M
▼ 90.3% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 262.9M
Revenue, FY2025 · full 6-year series below
Revenue $M Net income $M
FY2025 · Revenue 262.9 · Net income -68.6
100M200M-100M-200M
202020232025
Compound annual growth
−2.6%
+26.6%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +26.6% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−26 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating 1.8% · Net -26.1%
-100%-200%
202020222025
ROE
FY2022 · ROE -176.2%
-5000%
202020222025
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.

Return on equity has no reading this year — return on capital employed, just below, still does: 1%.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 1.6
10M20M-40M-80M
202020222025

Total assetsUSD 422.3M
EquityUSD -115.3M
CashUSD 24.0M
Gross debtUSD 205.8M
Net debtUSD 181.8M
Current ratio1.03×

Equity was zero or negative — liabilities equaled or exceeded assets. No ratio is shown.

The 6-year record

6 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
JUSH, 6-year financial record
Metric 202520242023202220212020
Revenue $B0.30.30.30.30.20.1
Operating income $B0.00.0−0.0−0.2−0.0−0.0
EBITDA $B0.00.00.0−0.2−0.0−0.0
Income tax $B0.00.00.00.00.00.0
Net income $B−0.1−0.0−0.1−0.20.0−0.2
Free cash flow $B0.00.0−0.0−0.1−0.1−0.0
EPS, diluted $−0.35−0.25−0.33−1.44−0.42−1.94
Dividend / sh $◌◌◌◌◌◌
Payout % — not applicable: no dividend——————
ROE %———−176.221.9−8692.0
Shares out B◌◌0.200.20◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 28 reconciliationsAUDITED

Reconciled in 6 of the 6 fiscal years we could check. 28 checks were skipped: the balance sheet is not tagged before 2021. 13 checks were skipped: EPS is not tagged before 2020. 13 checks were skipped: revenue is not tagged before 2020.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inoutside the United States — SEC code A1
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2020

Share this section

Download image